Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
Patients with hard-to-treat autoimmune hepatitis (AIH) or primary biliary cholangitis (PBC) are defined a posteriori as those who do not show a sufficient response or are intolerant to pharmacological treatments, thus not achieving biochemical surrogate endpoints that are associated with long-term l...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Korean Association for the Study of the Liver
2025-01-01
|
| Sarja: | Clinical and Molecular Hepatology |
| Aiheet: | |
| Linkit: | http://e-cmh.org/upload/pdf/cmh-2024-0821.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|